Xylose

Xylose

SCHEMBL4484244

NC(=O)c1cccnc1.O=C[C@H](O)[C@H](O)[C@H](O)CO.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 2/20 0.48
SIRT1 Q96EB6 2/20 0.48
SIRT3 Q9NTG7 2/20 0.48
F7 P08709 1/20 0.48
F3 P13726 1/20 0.48
SARM1 Q6SZW1 1/20 0.48
SIRT6 Q8N6T7 1/20 0.48
SIRT5 Q9NXA8 1/20 0.48
SIRT4 Q9Y6E7 1/20 0.48
THRB P10828 1/20 0.38
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
ALDH1A1 P00352 4/20 0.34
APP P05067 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xylose SCHEMBL23706155 0.93 F7 (0.52) SIRT2SIRT1SIRT3F7F3
Xylose SCHEMBL23925306 0.91 F7 (0.58) SIRT2SIRT1SIRT3F7F3
Xylose SCHEMBL938610 0.91 F7 (0.58) SIRT2SIRT1SIRT3F7F3
Xylose SCHEMBL20423632 0.90 F7 (0.56) SIRT2SIRT1SIRT3F7F3
Xylose SCHEMBL28724079 0.90 F7 (0.56) SIRT2SIRT1SIRT3F7F3
Demannose SCHEMBL27666893 0.87 F7 (0.56) SIRT2SIRT1SIRT3F7F3
Xylose SCHEMBL28364957 0.87 F7 (0.43) SIRT2SIRT1SIRT3F7F3
Niacinamide SCHEMBL6811151 0.86 SIRT2 (0.49) SIRT2SIRT1SIRT3F7F3
Cadaverine Tartrate SCHEMBL28825318 0.85 F7 (0.51) SIRT2SIRT1SIRT3F7F3
Xylose SCHEMBL28825332 0.85 F7 (0.51) SIRT2SIRT1SIRT3F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504489-B2 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2009-03-17 US disclosed
US-7056894-B2 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2006-06-06 US disclosed
US-20060084616-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2006-04-20 US disclosed
EP-1370139-A2 INHIBITORS OF ADP-RIBOSYL TRANSFERASES, CYCLASES, AND HYDROLASES, AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2003-12-17 EP disclosed
US-20020132783-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. 2002-09-19 US disclosed
WO-2002059084-A2 INHIBITORS OF ADP-RIBOSYL TRANSFERASES, CYCLASES, AND HYDROLASES, AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2002-08-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020132783-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof CD38, ADPRS, NTPCR SIRT2 731/4885SIRT1 285/4885SIRT3 517/4885
US-20060084616-A1 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof CD38, ADPRS, NTPCR SIRT2 692/4885SIRT1 261/4885SIRT3 493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.